PR90140

NEW YORK, June 17, 2021 /PRNewswire=KYODO JBN/ --

- A Hearing to Consider Confirmation of the Chapter 11 Plan May Affect Your

Rights.

- Confirmation Hearing August 9, 2021.

The following statement is being issued by Prime Clerk* regarding the Purdue

Pharma L.P. bankruptcy.

WHAT IS THIS ABOUT?

On June 3, 2021, as part of Purdue Pharma L.P.'s bankruptcy proceedings, the

United States Bankruptcy Court for the Southern District of New York entered an

order called the "Disclosure Statement Order" that:

    (a)   Authorized Purdue Pharma L.P. and its affiliated debtors and

     debtors in possession to solicit acceptances of the Fifth Amended

     Joint Chapter 11 Plan of Reorganization of Purdue Pharma L.P. and

     Its Affiliated Debtors, which includes (a) releases of any actual

     or potential claims against Sackler family members, and certain other

     individuals and related entities, relating to Purdue Pharma L.P. and

     its affiliated debtors (including Purdue prescription opioids, like

     OxyContin, or other prescription opioids manufactured or sold by

     Purdue); and (b) an injunction requiring that certain claims against

     the released parties be asserted only against trusts established under

     the plan;

    (b)   Approved the Disclosure Statement for Fifth Amended Joint Chapter

     11 Plan for Purdue Pharma L.P. and Its Affiliated Debtors as

     containing "adequate information" pursuant to section 1125 of the

     Bankruptcy Code;

    (c)   Approved the solicitation materials and documents to be included

     in solicitation packages; and

    (d)   Approved procedures for soliciting, receiving, and tabulating

     votes on the plan and for filing objections to the plan.

The Court will consider confirmation of the plan at the Confirmation Hearing.

WHEN IS THE HEARING?

The Confirmation Hearing will be held on August 9, 2021, at 10 a.m., prevailing

Eastern Time, before the Honorable Robert D. Drain, in the United States

Bankruptcy Court for the Southern District of New York, located at 300

Quarropas Street, White Plains, New York 10601-4140. The hearing will be

conducted via Zoom videoconference for those who will be participating in the

Confirmation Hearing(1) if General Order M-543 is still in effect or unless

otherwise ordered by the Bankruptcy Court.  

The Confirmation Hearing may be extended and rescheduled by the Court or the

Debtors without further notice by an agenda filed with the Court, and/or by a

Notice of Adjournment filed with the Court and delivered to all parties who are

entitled to notice.

WHAT ARE YOUR OPTIONS?

Vote on the Plan: Your vote must be submitted so it is actually received on or

before July 14, 2021, at 4:00 p.m., prevailing Eastern Time. Detailed

instructions on how to vote are available at PurduePharmaClaims.com or by

calling (844) 217-0912 (toll free) or (347) 859-8093 (international). Failure

to follow instructions properly may disqualify your vote.

Object to the Plan: An objection must be submitted so that it is actually

received on or before July 19, 2021, at 4:00 p.m., prevailing Eastern Time.

Detailed instructions on how to file an objection are available at

PurduePharmaClaims.com or by calling (844) 217-0912 (toll free) or (347)

859-8093 (international).

Allowance Request: If you believe that you hold a claim against Purdue Pharma

L.P. that is not currently entitled to vote but that you believe should be

entitled to vote, you can request the allowance of such claim for voting

purposes. To do so, you must file a motion with the Court on or before July 19,

2021, at 4:00 p.m., prevailing Eastern Time. Detailed instructions on how to

file an allowance request are available at PurduePharmaClaims.com or by calling

(844) 217-0912 (toll free) or (347) 859-8093 (international).

If the plan is confirmed, anyone with an actual or potential claim against

Purdue Pharma L.P. or any of its affiliated debtors, or with an actual or

potential claim against Sackler family members, and certain other individuals

and related entities, relating to Purdue Pharma L.P. and its affiliated debtors

(including Purdue prescription opioids, like OxyContin, or other prescription

opioids manufactured or sold by Purdue), will be bound by the terms of the

plan, including the releases and injunctions contained therein.

This is only a summary. For more information:

    -- Call: (844) 217-0912 (toll free) or (347) 859-8093 (international)

    -- Visit: PurduePharmaClaims.com

    -- Write: Purdue Pharma Ballot Processing, c/o Prime Clerk LLC, One

       Grand Central Place, 60 East 42nd Street, Suite 1440, New York, NY 10165

    -- Email: purduepharmainfo@primeclerk.com

Please be advised that Prime Clerk LLC is authorized to answer questions about,

and provide additional copies of, solicitation materials, but may not advise

you as to whether you should vote to accept or reject the plan or provide any

legal advice.

(1)         Parties or members of the public who wish to participate in the

Confirmation Hearing should consult the Court's calendar with respect to the

day of the Confirmation Hearing at

https://www.nysb.uscourts.gov/calendars/rdd.html for information regarding how

to be added as a participant.  Members of the public who wish to listen to, but

not participate in, the Confirmation Hearing free of charge may do so

telephonically at a number to be provided on the Debtors' case website at:

PurduePharmaClaims.com (

https://c212.net/c/link/?t=0&l=en&o=3197429-1&h=2045692711&u=https%3A%2F%2Fpurduepharmaclaims.com%2F&a=PurduePharmaClaims.com

).

SOURCE  *Prime Clerk the Court-Appointed Claims and Noticing Agent

CONTACT: Michele Sharp +1 (203) 588-7584